why choose us

First received: August 23, 2023

Clinical Trial: ZN-c3 + Gemcitabine in Pancreatic Cancer

Study Status: Completed

Recruit Status: RECRUITING

Condition: Advanced Pancreatic Adenocarcinoma

Study Type: INTERVENTIONAL


Official Title: Phase 2 Single Arm Trial Testing the ZN-c3 WEE1 Inhibitor in Combination With Gemcitabine in Second-Line Advanced Pancreatic Adenocarcinoma

Brief Summary: This study is being done to test the safety and effectiveness of combining ZN-c3 and Gemcitabine in participants with pancreatic cancer.The names of the study drugs involved in this study are:ZN-c3 (a small molecule inhibitor of the WEE1 tyrosine kinase)Gemcitabine (a nucleoside metabolic inhibitor)

Read more